Validity of administrative codes associated with cirrhosis in Sweden

Bonnie Bengtsson1,2, Johan Askling3,4, Jonas F Ludvigsson5,6,7,8

  • 1Division of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.

Insights

The International Classification of Diseases, 10th revision (ICD-10) codes for cirrhosis and its complications generally show high validity in the Swedish National Patient Register (NPR). However, coding for ascites requires combining with chronic liver disease codes for accuracy.

Area of Science:

  • Hepatology
  • Medical Informatics
  • Public Health Surveillance

Background:

  • Cirrhosis is a significant global cause of liver-related mortality.
  • Validation studies for administrative coding of cirrhosis diagnoses are limited.
  • Accurate coding is crucial for epidemiological research and healthcare management.

Purpose of the Study:

  • To validate the accuracy of International Classification of Diseases, 10th revision (ICD-10) codes for cirrhosis and its complications.
  • To assess the reliability of the Swedish National Patient Register (NPR) for cirrhosis-related diagnoses.

Main Methods:

  • Random selection of 750 patients with specific ICD-10 codes for cirrhosis, oesophageal varices, hepatocellular carcinoma (HCC), or ascites from the NPR (2000-2016).
  • Inclusion of hospitalisation events and specialised outpatient visits.
  • Calculation of positive predictive values (PPVs) using patient charts as the gold standard.

Main Results:

  • High PPVs were observed for alcohol-related cirrhosis (93%), unspecified cirrhosis (91%), and oesophageal varices (96%).
  • Hepatocellular carcinoma (HCC) coding showed a PPV of 84%.
  • The PPV for liver-related ascites was low (43%) but increased to 93% when combined with chronic liver disease codes.

Conclusions:

  • ICD-10 codes for cirrhosis, oesophageal varices, and HCC demonstrate high validity in the NPR.
  • Coding for ascites requires augmentation with a chronic liver disease code to ensure acceptable validity.
  • Findings support the use of NPR data for cirrhosis research with specific coding considerations for ascites.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
101
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
265
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
126
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
841
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
373